Related Experiment Videos
CCL chemokines and asthma
1Instituto Nacional de Enfermedades Respiratorias, Calz de Tlalpan 4502, Mexico DF, Mexico. lmteran@diego.iner.gob.mx
Immunology Today
|April 27, 2000
Summary
Airway eosinophilia, common in asthma, involves eosinophils causing tissue damage. Targeting chemokines, which recruit these cells, presents a new therapeutic strategy for asthma.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Background:
- Airway eosinophilia is a hallmark of bronchial asthma.
- Eosinophils contribute to asthma-related tissue damage via toxic mediators.
- Cytokine superfamily members, specifically chemokines, are key in eosinophil recruitment.
Purpose of the Study:
- To explore the role of chemokines in eosinophil recruitment in asthma.
- To identify novel therapeutic targets for asthma based on chemokine-eosinophil interactions.
Main Methods:
- Review of current literature on asthma pathophysiology.
- Analysis of chemokine function in eosinophil migration.
- Investigation of therapeutic potential of chemokine modulation.
Main Results:
- Chemokines are critical for eosinophil recruitment to the airways.
- Eosinophil-derived mediators cause significant airway tissue damage.
- Targeting chemokine pathways offers a promising therapeutic avenue.
Conclusions:
- Understanding chemokine-mediated eosinophil recruitment is vital for asthma treatment.
- Modulating chemokine activity represents a novel therapeutic strategy for bronchial asthma.